Skip to main content
    S

    Sotera Health Co (SHC)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $16.25
    -0.36 (-2.17%)

    Market Cap: $4.74B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sotera Health Co (SHC) Earnings: Report Dates and Results

    Updated Nov 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Sotera Health (SHC) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, Sotera Health reported EPS of $0.27, above the $0.24 estimate. It beat the EPS estimate in each of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    84%(21/25)
    Avg Surprise
    +6.97%
    Streak
    8 Q

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.26
    Range$0.25 - $0.28
    11 analysts
    Revenue Consensus
    $321.41M
    Range$308.70M - $341.04M
    11 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.20
    Range$0.18 - $0.22
    8 analysts
    EPS Estimate DriftChange to current
    90d ago$0.20+1.1%
    60d ago$0.20+1.1%
    30d ago$0.20+0.4%
    7d ago$0.20+0.4%
    Current$0.20
    Revenue Consensus
    $294.32M
    Range$292.67M - $296.33M
    6 analysts

    Next Report

    SHC has an expected report date of Feb 22, 2027.

    SHC Earnings Call

    The latest SHC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 25 quarters below that had an estimate, SHC beat 21, missed 3 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $324.89M, up 4.4% from $311.31M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.27$0.24N/A+12.50%Beat+3.8%101 up, 0 downNov 3, 2026$324.89M
    Jun 30, 2026$0.24$0.22N/A+9.09%Beat+20.0%100 up, 2 downAug 6, 2026$321.38M
    Mar 31, 2026$0.18$0.17$0.15 - $0.18+5.88%Beat+28.6%100 up, 1 downMay 5, 2026$280.05M
    Dec 31, 2025$0.26$0.24$0.24 - $0.25+7.35%Beat+23.8%106 up, 0 downFeb 24, 2026$303.44M
    Sep 30, 2025$0.26$0.22$0.21 - $0.22+18.18%Beat+52.9%71 up, 0 downNov 4, 2025$311.31M
    Jun 30, 2025$0.20$0.17$0.17 - $0.18+17.65%Beat+5.3%70 up, 8 downAug 8, 2025$294.34M
    Mar 31, 2025$0.14$0.12$0.11 - $0.13+16.67%Beat+7.7%80 up, 1 downMay 1, 2025$254.52M
    Dec 31, 2024$0.21$0.20$0.19 - $0.21+4.01%Beat-19.2%81 up, 1 downFeb 27, 2025$290.20M
    Sep 30, 2024$0.17$0.18$0.18 - $0.19-5.56%Miss-19.0%81 up, 0 downNov 5, 2024$285.47M
    Jun 30, 2024$0.19$0.16$0.16 - $0.17+18.75%Beat-9.5%80 up, 0 downAug 5, 2024$276.59M
    Mar 31, 2024$0.13$0.12$0.11 - $0.15+8.33%Beat0.0%70 up, 1 downMay 2, 2024$248.18M
    Dec 31, 2023$0.26$0.26$0.24 - $0.280.00%In line+4.0%71 up, 0 downFeb 27, 2024$310.24M
    Sep 30, 2023$0.21$0.20$0.18 - $0.21+5.00%Beat-8.7%60 up, 0 downNov 1, 2023$263.18M
    Jun 30, 2023$0.21$0.17$0.16 - $0.19+23.53%Beat-22.2%70 up, 0 downAug 3, 2023$255.28M
    Mar 31, 2023$0.13$0.14$0.13 - $0.14-7.14%Miss-40.9%70 up, 0 downMay 3, 2023$220.59M
    Dec 31, 2022$0.25$0.22$0.21 - $0.23+13.64%Beat+8.7%70 up, 0 downFeb 28, 2023N/A
    Sep 30, 2022$0.23$0.22$0.21 - $0.23+4.55%Beat+9.5%80 up, 0 downNov 2, 2022$248.70M
    Jun 30, 2022$0.27$0.24$0.23 - $0.25+12.50%Beat+3.8%80 up, 0 downAug 4, 2022$266.64M
    Mar 31, 2022$0.22$0.20$0.18 - $0.20+10.00%Beat+22.2%80 up, 0 downMay 5, 2022$236.75M
    Dec 31, 2021$0.23$0.22$0.21 - $0.23+4.55%Beat+155.6%9N/AMar 1, 2022$241.25M
    Sep 30, 2021$0.21$0.20$0.20 - $0.21+5.00%Beat+950.0%9N/ANov 10, 2021$226.16M
    Jun 30, 2021$0.26$0.21$0.20 - $0.22+23.81%BeatN/A9N/AAug 12, 2021$251.92M
    Mar 31, 2021$0.18$0.16$0.15 - $0.17+12.50%Beat+1551.4%9N/AMay 13, 2021$212.15M
    Dec 31, 2020$0.09$0.07$0.06 - $0.09+28.57%Beat+725.7%8N/AMar 9, 2021$216.84M
    Sep 30, 2020$0.02$0.08N/A-75.00%MissN/AN/AN/ANov 19, 2020$200.03M
    Jun 30, 2020Not reportedN/AN/AN/ANot reportedN/AN/AN/ASep 30, 2020$213.09M
    Mar 31, 2020$0.01N/AN/AN/AN/A-60.1%N/AN/AJun 29, 2020$188.20M
    Dec 31, 2019$0.01N/AN/AN/AN/A-60.1%N/AN/AMar 31, 2020$193.49M
    Jun 30, 2019-$0.02N/AN/AN/AN/AN/AN/AN/ASep 30, 2019$194.76M
    Mar 31, 2019$0.03N/AN/AN/AN/AN/AN/AN/AJun 29, 2019$194.76M
    Dec 31, 2018$0.03N/AN/AN/AN/AN/AN/AN/AMar 30, 2019N/A
    Last 31 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.86, up 22.9% from the year before. It was $0.03 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.86+22.9%
    Dec 31, 2024$0.70-13.6%
    Dec 31, 2023$0.81-16.5%
    Dec 31, 2022$0.97+10.2%
    Dec 31, 2021$0.88+627.9%
    Dec 31, 2020$0.12+763.6%
    Dec 31, 2019$0.01N/A
    Dec 31, 2018$0.03N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,500 words across 13 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,52813
    2026Q2Jun 30, 20267,57015
    2026Q1Mar 31, 20265,09313
    2025Q4Dec 31, 20256,29414
    2025Q3Sep 30, 20254,82611
    2025Q2Jun 30, 20255,56111
    2025Q1Mar 31, 20255,93911
    2024Q4Dec 31, 20246,34613

    2026Q3 Earnings Call

    Opening remarks

    Jason Peterson Vice President of Investor Relations Good morning, and welcome to Sotera Health's third quarter earnings call. Today's press release and earnings presentation are available on the Investors section of our website at soterahealth.com. This webcast is being recorded, and a replay will also be available on the Investors section of the Sotera Health website shortly after the call. Joining me today are Chief Executive Officer Alton E. Shader, Chief Financial Officer Jonathan Lyons, and Executive Chairman Michael Petras. During today's call, some of our comments may be considered forward-looking statements. The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to Sotera Health's SEC filings and the forward-looking statements slide at the beginning of the earnings presentation for a description of these risks and uncertainties. The company assumes no obligation to update any such forward-looking statements. Please note that during the discussion today, the company will present both GAAP and non-GAAP financial measures, including adjusted EBITDA, adjusted EBITDA margin, tax rate applicable to adjusted net income, adjusted net income, adjusted EPS, net debt, and net leverage ratio, as well as constant-currency comparisons. A reconciliation of GAAP to non-GAAP measures for all relevant periods may be found in the schedules attached to the company's press release and in the supplemental slides to the earnings presentation. The operator will be assisting with the Q&A portion of the call today. Please limit yourself to one question and one follow-up. For further questions, feel free to reach out to the Investor Relations team. I will now turn the call over to Sotera Health CEO, Alton E. Shader.

    Alton E. Shader CEO Good morning, and thank you for joining us. Today, we reported solid top- and bottom-line growth versus the third quarter of 2025, driven by strong execution and sequential adjusted EBITDA margin improvement of nearly 100 basis points. For the third quarter, we delivered constant-currency revenue growth of 4.4% and constant-currency adjusted EBITDA growth of 4% versus the same period last year. Sterigenics continued to perform well, generating 8.2% constant-currency revenue growth and 57 basis points of segment income margin expansion, despite experiencing some softness in the medical device market during the quarter, which has continued into the early part of Q4. Nelson Labs delivered another strong quarter, with revenue increasing 9.2% on a constant-currency basis as the team continued to execute on complex projects to support our customers' regulatory needs. As expected, Nordion results reflected the timing of cobalt-60 harvest schedules. The Nordion teams did a great job delivering critical cobalt-60 shipments for their customers and expanded segment income margins by 71 basis points.

    Frequently Asked Questions About SHC

    When is Sotera Health's next earnings date?

    Sotera Health's next earnings report is expected for Feb 22, 2027.

    Did SHC beat earnings estimates last quarter?

    Yes. Sotera Health reported EPS of $0.27 for the quarter ended Sep 30, 2026, above the $0.24 estimate, a 12.50% surprise.

    What EPS do analysts expect from SHC next quarter?

    The consensus EPS estimate for Sotera Health for the quarter ending Dec 31, 2026 is $0.26 from 11 analysts, with estimates from $0.25 to $0.28.

    How often does SHC beat earnings estimates?

    Sotera Health beat the EPS estimate in each of the last 8 quarters, with an average surprise of +11.42%.